BioSpace News Archive

The global professional services firm ZS announced today that it has entered into a strategic partnership through a supporting multimillion dollar investment in IgniteData, a U.K.-based digital health startup shaping the future of clinical research through its Archer technology.

Partnership between Temedica, a leading digital health and health insights company, and NOVENTI Health SE, the largest provider of enterprise resource planning (ERP) systems and claims management solutions for pharmacies in Germany

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced results from its REDUCE LAP-HF II randomized clinical trial, investigating the safety and efficacy of the Corvia® Atrial Shunt in heart failure patients with preserved or mildly reduced ejection fraction.

Syner-G BioPharma Group, a leading provider of Chemistry, Manufacturing, and Controls technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, announced the acquisition of Impact Pharmaceutical Services.

I am pleased to welcome Erin Parsons to our Board of Directors,” said Brian M. Strem, Ph.D, President and CEO of Kiora.

Patent claims on synergistic application of cepharanthine, cabazitaxel and other taxane family members used in combination to treat primary, metastatic and chemotherapy-resistant prostate cancer.

Mr. Nijjar has worked extensively with public companies across various industries, helping them navigate the regulatory and financial reporting environment.

Eli Lilly and Company will participate in the Guggenheim Oncology Conference on Wednesday, Feb. 9, 2022.

Kura Oncology, Inc. announced the expansion of its leadership team with three promotions: Mollie Leoni, M.D., to Senior Vice President, Clinical Development, Pete De Spain to Senior Vice President, Investor Relations and Corporate Communications, and Tom Doyle to Senior Vice President, Finance and Accounting.

Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today announced that Jae Kim, M.D., FACC, has been appointed as chief medical officer.